|
US2009311795A1
|
|
Bilateral control of functions traditionally regulated by only serotonin or only dopamine
|
|
US2007293571A1
|
|
Adminstration of dopa precursors with sources of dopa to effectuate optimal catecholamine neurotransmitter outcomes
|
|
WO2007032770A2
|
|
Serotonin and catecholamine segment optimization technology
|
|
US2006110325A1
|
|
Serotonin and catecholamine segment optimization technology
|
|
US2005233008A1
|
|
Comprehensive pharmacologic therapy for treatment of a dysfunction
|
|
US7268161B2
|
|
Comprehensive pharmacologic therapy for treatment of obesity including cysteine
|
|
BRPI0407619A
|
|
serotonin and catecholamine system segment optimization technology
|
|
EP1490073A2
|
|
Serotonin and catecholamine system segment optimization techonology
|
